Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
Journal of Experimental Botany|February 6, 2024
The 'Candidatus Phytoplasma ziziphi' effectors SJP1/2 negatively control leaf size by stabilizing the transcription factor ZjTCP2 in jujubeFuli Ma, Yunyan Zheng, Ning Zhang, et al.Aging Clinical and Experimental Research|December 29, 2025
Management of cardiometabolic risk factors in cardiovascular high-risk populations with varying cognitive levelsTing Shen, Meiqi Zhao, Siyuan Qiao, et al.Applied Microbiology and Biotechnology|May 24, 2018
Rapid development of stable transgene CHO cell lines by CRISPR/Cas9-mediated site-specific integration into C12orf35Menglin Zhao, Jiaxian Wang, Manyu Luo, et al.Nano Letters|February 18, 2021
Ultrastable FeCo Bifunctional Electrocatalyst on Se-Doped CNTs for Liquid and Flexible All-Solid-State Rechargeable Zn-Air BatteriesHongwei Zhang, Meiqi Zhao, Haoran Liu, et al.Biochemical and Biophysical Research Communications|April 11, 2019
Molecular dynamics based improvement of the solubilizing self-cleavable tag Z<sub>basic</sub>-ΔI-CM application in the preparation of recombinant proteins in Escherichia coliHan Luo, Lifu Hu, Buyong Ma, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|July 21, 2025
Intensive Blood Pressure Control in Patients With Diabetes and Previous Stroke: A Post-Hoc Analysis of ACCORD-BP TrialZhixian Wang, Jue Wang, Liu He, et al.Nucleic Acids Research|November 24, 2025
Developing a general AI model for integrating diverse genomic modalities and comprehensive genomic knowledgeZhenhao Zhang, Xinyu Bao, Linghua Jiang, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 25, 2019
Development of a recombinant human IL-15·sIL-15Rα/Fc superagonist with improved half-life and its antitumor activity alone or in combination with PD-1 blockade in mouse modelMeiqi Zhao, Manyu Luo, Yueqing Xie, et al.Journal of Translational Medicine|February 28, 2025
RPL22L1 fosters malignant features of cervical cancer via the modulation of DUSP6-ERK axisDongmei Zhang, Meiqi Zhao, Ping Jiang, et al.Cell Death & Disease|November 21, 2023
RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastomaYunping Chen, Yu Mu, Qing Guan, et al.Pageof 6